# Welltower Inc.: financial statements, quarterly

WELL · NYSE · CIK 766704 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/well.md) · [Financials](/companies/well/financials.md) · [Filings](/companies/well/filings.md) · [Insiders](/companies/well/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/well/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,263 d](/filings/0000766704-26-000010.md) | [1,360](/filings/0000766704-25-000020.md) | [1,393](/filings/0000766704-25-000029.md) | [1,512](/filings/0000766704-25-000040.md) | [1,762 d](/filings/0000766704-26-000010.md) | [1,865](/filings/0000766704-26-000021.md) | [1,971](/filings/0000766704-26-000030.md) | [2,061](/filings/0000766704-26-000046.md) | [2,556 d](/filings/0000766704-26-000010.md) | [2,781](/filings/0000766704-26-000021.md) | [2,985](/filings/0000766704-26-000030.md) | [3,121](/filings/0000766704-26-000046.md) |
| Cost of revenue | $m | [1,036 d](/filings/0000766704-26-000010.md) | [1,097](/filings/0000766704-25-000020.md) | [1,111](/filings/0000766704-25-000029.md) | [1,213](/filings/0000766704-25-000040.md) | [1,409 d](/filings/0000766704-26-000010.md) | [1,462](/filings/0000766704-26-000021.md) | [1,515](/filings/0000766704-26-000030.md) | [1,577](/filings/0000766704-26-000046.md) | [1,934 d](/filings/0000766704-26-000010.md) | [2,055](/filings/0000766704-26-000021.md) | [2,150](/filings/0000766704-26-000030.md) | [2,246](/filings/0000766704-26-000046.md) |
| Selling, general and administrative | $m | [44.3 d](/filings/0000766704-26-000010.md) | [53.3](/filings/0000766704-25-000020.md) | [55.6](/filings/0000766704-25-000029.md) | [77.9](/filings/0000766704-25-000040.md) | [48.7 d](/filings/0000766704-26-000010.md) | [63.8](/filings/0000766704-26-000021.md) | [64.2](/filings/0000766704-26-000030.md) | [63.1](/filings/0000766704-26-000046.md) | [1,557 d](/filings/0000766704-26-000010.md) | [67.5](/filings/0000766704-26-000021.md) | [67.5](/filings/0000766704-26-000030.md) | [67.2](/filings/0000766704-26-000046.md) |
| Income tax | $m | [(4.8) d](/filings/0000766704-26-000010.md) | [6.2](/filings/0000766704-25-000020.md) | [1.1](/filings/0000766704-25-000029.md) | [(4.7)](/filings/0000766704-25-000040.md) | [0.1 d](/filings/0000766704-26-000010.md) | [(5.5)](/filings/0000766704-26-000021.md) | [1.1](/filings/0000766704-26-000030.md) | [2.3](/filings/0000766704-26-000046.md) | [(5.0) d](/filings/0000766704-26-000010.md) | [11.6](/filings/0000766704-26-000021.md) | [(62.0)](/filings/0000766704-26-000030.md) | [7.1](/filings/0000766704-26-000046.md) |
| Net income | $m | [88.4 d](/filings/0000766704-26-000010.md) | [132](/filings/0000766704-25-000020.md) | [261](/filings/0000766704-25-000029.md) | [457](/filings/0000766704-25-000040.md) | [124 d](/filings/0000766704-26-000010.md) | [257](/filings/0000766704-26-000021.md) | [305](/filings/0000766704-26-000030.md) | [282](/filings/0000766704-26-000046.md) | [118 d](/filings/0000766704-26-000010.md) | [752](/filings/0000766704-26-000021.md) | [463](/filings/0000766704-26-000030.md) | [415](/filings/0000766704-26-000046.md) |
| Diluted EPS | $ per share | not reported | [0.22](/filings/0000766704-25-000020.md) | [0.42](/filings/0000766704-25-000029.md) | [0.73](/filings/0000766704-25-000040.md) | not reported | [0.40](/filings/0000766704-26-000021.md) | [0.45](/filings/0000766704-26-000030.md) | [0.41](/filings/0000766704-26-000046.md) | not reported | [1.02](/filings/0000766704-26-000021.md) | [0.61](/filings/0000766704-26-000030.md) | [0.54](/filings/0000766704-26-000046.md) |
| Basic EPS | $ per share | not reported | [0.22](/filings/0000766704-25-000020.md) | [0.42](/filings/0000766704-25-000029.md) | [0.74](/filings/0000766704-25-000040.md) | not reported | [0.40](/filings/0000766704-26-000021.md) | [0.46](/filings/0000766704-26-000030.md) | [0.42](/filings/0000766704-26-000046.md) | not reported | [1.04](/filings/0000766704-26-000021.md) | [0.63](/filings/0000766704-26-000030.md) | [0.55](/filings/0000766704-26-000046.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.0](/filings/0000766704-25-000009.md) | [2.4](/filings/0000766704-24-000022.md) | [2.8](/filings/0000766704-24-000033.md) | [3.6](/filings/0000766704-24-000039.md) | [3.5](/filings/0000766704-26-000010.md) | [3.5](/filings/0000766704-25-000020.md) | [4.4](/filings/0000766704-25-000029.md) | [6.8](/filings/0000766704-25-000040.md) | [5.0](/filings/0000766704-26-000046.md) | [4.7](/filings/0000766704-26-000021.md) | [2.0](/filings/0000766704-26-000030.md) | [2.3](/filings/0000766704-26-000046.md) |
| Total assets | $bn | [44.0](/filings/0000766704-25-000009.md) | [44.6](/filings/0000766704-24-000022.md) | [45.5](/filings/0000766704-24-000033.md) | [49.0](/filings/0000766704-24-000039.md) | [51.0](/filings/0000766704-26-000010.md) | [53.3](/filings/0000766704-25-000020.md) | [55.8](/filings/0000766704-25-000029.md) | [59.5](/filings/0000766704-25-000040.md) | [67.3](/filings/0000766704-26-000046.md) | [67.2](/filings/0000766704-26-000021.md) | [69.9](/filings/0000766704-26-000030.md) | [73.7](/filings/0000766704-26-000046.md) |
| Total liabilities | $bn | [17.6](/filings/0000766704-25-000009.md) | [16.0](/filings/0000766704-24-000022.md) | [15.8](/filings/0000766704-24-000033.md) | [17.9](/filings/0000766704-24-000039.md) | [18.5](/filings/0000766704-26-000010.md) | [18.7](/filings/0000766704-25-000020.md) | [19.3](/filings/0000766704-25-000029.md) | [20.2](/filings/0000766704-25-000040.md) | [24.1](/filings/0000766704-26-000046.md) | [22.3](/filings/0000766704-26-000021.md) | [22.2](/filings/0000766704-26-000030.md) | [23.8](/filings/0000766704-26-000046.md) |
| Long-term debt | $bn | [15.7](/filings/0000766704-24-000008.md) | [14.2](/filings/0000766704-24-000022.md) | [13.9](/filings/0000766704-24-000033.md) | [15.8](/filings/0000766704-24-000039.md) | [15.5](/filings/0000766704-25-000009.md) | [15.7](/filings/0000766704-25-000020.md) | [16.0](/filings/0000766704-25-000029.md) | [16.9](/filings/0000766704-25-000040.md) | [19.2](/filings/0000766704-26-000010.md) | [17.9](/filings/0000766704-26-000021.md) | [17.7](/filings/0000766704-26-000030.md) | [18.2](/filings/0000766704-26-000046.md) |
| Shareholders' equity | $bn | [25.4](/filings/0000766704-25-000009.md) | [27.5](/filings/0000766704-24-000022.md) | [29.0](/filings/0000766704-24-000033.md) | [30.3](/filings/0000766704-24-000039.md) | [32.0](/filings/0000766704-26-000010.md) | [34.0](/filings/0000766704-25-000020.md) | [35.9](/filings/0000766704-25-000029.md) | [38.8](/filings/0000766704-25-000040.md) | [42.1](/filings/0000766704-26-000046.md) | [43.8](/filings/0000766704-26-000021.md) | [46.4](/filings/0000766704-26-000030.md) | [48.6](/filings/0000766704-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [371 d](/filings/0000766704-26-000010.md) | [407](/filings/0000766704-25-000020.md) | [605 d](/filings/0000766704-25-000029.md) | [685 d](/filings/0000766704-25-000040.md) | [559 d](/filings/0000766704-26-000010.md) | [599](/filings/0000766704-26-000021.md) | [770 d](/filings/0000766704-26-000030.md) | [858 d](/filings/0000766704-26-000046.md) | [654 d](/filings/0000766704-26-000010.md) | [670](/filings/0000766704-26-000021.md) | [1,004 d](/filings/0000766704-26-000030.md) | [1,003 d](/filings/0000766704-26-000046.md) |
| Dividends paid | $m | [338 d](/filings/0000766704-26-000010.md) | [353](/filings/0000766704-25-000020.md) | [366 d](/filings/0000766704-25-000029.md) | [409 d](/filings/0000766704-25-000040.md) | [418 d](/filings/0000766704-26-000010.md) | [431](/filings/0000766704-26-000021.md) | [439 d](/filings/0000766704-26-000030.md) | [497 d](/filings/0000766704-26-000046.md) | [510 d](/filings/0000766704-26-000010.md) | [520](/filings/0000766704-26-000021.md) | [527 d](/filings/0000766704-26-000030.md) | [615 d](/filings/0000766704-26-000046.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [494](/filings/0000766704-24-000022.md) | [502](/filings/0000766704-24-000033.md) | [525](/filings/0000766704-24-000039.md) | [578](/filings/0000766704-25-000020.md) | [605](/filings/0000766704-25-000029.md) | [618](/filings/0000766704-25-000040.md) | [654](/filings/0000766704-26-000021.md) | [668](/filings/0000766704-26-000030.md) | [685](/filings/0000766704-26-000046.md) | [726](/filings/0000766704-26-000021.md) | [738](/filings/0000766704-26-000030.md) | [755](/filings/0000766704-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 733,609,863 at 2026-10-23, from the cover of the [10-Q filed 2026-10-27](/filings/0000766704-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 17:23 ET. No prices; not investment advice.